LILLY ELI & PHARMACEUTICAL DIV -- UC5017 FLUOXETINE HYDROCHLORIDE ORAL SOLUTION
=======================================================
Material Safety Data Sheet
=======================================================
MSDS Num: CDFVX
MSDS NAME: UC5017 FLUOXETINE HYDROCHLORIDE ORAL SOLUTION
Responsible Party
Name: LILLY ELI & CO PHARMACEUTICAL DIV
Address: 307 E MCCARTY ST
City: INDIANAPOLIS IN 48285-5000
Info Phone: 317-276-2000/317-276-3494
Emergency Phone Number: 317-276-2000/317-276-3494
Review Ind: Y
Published: Y
=======================================================
Preparer Co. when other than Responsible Party Co.
=======================================================
Assigned Ind: Y
Name: LILLY ELI & CO PHARMACEUTICAL DIV
Address: LILLY CORPORATE CENTER
City: INDIANAPOLIS IN 46285
=======================================================
Contractor Summary
=======================================================
Name: LILLY ELI & CO PHARMACEUTICAL DIV
Address: LILLY CORPORATE CENTER
City: INDIANAPOLIS IN 46285
Phone: 317-276-2000
Name: LILLY ELI AND CO PHARMACEUTICAL DIV
Address: LILLY CORPORATE CENTER
City: INDIANAPOLIS IN 46285
Phone: 317-276-2000
=======================================================
Ingredients
=======================================================
Cas: 59333-67-4
Name: FLUOXETINE HYDROCHLORIDE
% Wt: 0.35
-----------------------------
Cas: 57-50-1
RTECS #: WN6500000
Name: SUCROSE
% Wt: 47
ACGIH TLV: 10 MG/CUM
------------------------------
Cas: 56-81-5
RTECS #: MA8050000
Name: GLYCERINE, 1,2,3,-TRIHYDROXYPROPANE, GLYCEROL, ANHYDROUS GLYCERINE,
GLYCERIN *95-4*
% Wt: 15
ACGIH TLV: 10 MG/CUM (VAPOR)
------------------------------
Cas: 64-17-5
RTECS #: KQ6300000
Name: ETHANOL (ETHYL ALCOHOL), TECSOL, ALCOHOL, SYNASOL
% Wt: 0.23
Other REC Limits: 1900 MG/CUM
OSHA PEL: 1000 PPM
ACGIH TLV: 1000 PPM
------------------------------
Cas: 7732-18-5
RTECS #: ZC0110000
Name: WATER
% Wt: 36
=======================================================
Health Hazards Data
=======================================================
LD50 LC50 Mixture: ORAL LD50(RAT): 0.5 ML/KG
Route Of Entry Inds - Inhalation: YES
Skin: NO
Ingestion: NO
Carcinogenicity Inds - NTP: NO
IARC: NO
OSHA: NO
Effects of Exposure: SKIN: CONTACT DERMATITIS HAS BEEN REPORTED W/OCCUPATIONAL
EXPOSURE TO FLUOXETINE HYDROCHLORIDE. OVERDOSE AFTER SUSTAINED THERAPEUTIC
EXPOSURE TO FLUOXETINE HYDROCHLORIDE HAS RESULTED IN SEIZURES.
Explanation Of Carcinogenicity: NONE
Signs And Symptions Of Overexposure: CONTACT DERMATITIS HAS BEEN REPORTED
W/OCCUPATIONAL EXPOSURE TO FLUOXETINE HYDROCHLORIDE. OVERDOSE AFTER SUSTAINED
THERAPEUTIC EXPOSURE TO FLUOXETINE HYDROCHLORIDE HAS RESULTED IN SEIZURES.
Medical Cond Aggravated By Exposure: SEIZURE DISORDER
First Aid: EYES: FLUSH W/PLENTY OF WATER. SKIN: WASH W/SOAP & WATER.
INHALATION: REMOVE TO FRESH AIR. GIVE CPR IF NEEDED. INGESTION: DON'T INDUCE
VOMITING. IF AVAILABLE, ADMINISTER ACTIVATED CHARCOAL (6-8 HEAPIN G
TEASPOONS) W/2-3 GLASSES OF WATER. DON'T GIVE ANYTHING BY MOUTH TO AN
UNCONSIOUS PERSON. OBTAIN MEDICAL ATTENTION IN ALL CASES. (SEE SUPP)
=======================================================
Handling and Disposal
=======================================================
Spill Release Procedures: PREVENT FURTHER MIGRATION INTO ENVIRONMENT. USE
ABSORBENT/ADSORBENT MATERIAL TO SOLIDIFY LIQUIDS. WEAR PROTECTIVE EQUIPMENT,
INCLUDING EYE PROTECTION.
Waste Disposal Methods: DISPOSE OF IAW/FEDERAL, STATE & LOCAL REGULATIONS.
Handling And Storage Precautions: UNDER NORMAL USE & HANDLING CONDITIONS,
NO PROTECTIVE EQUIPMENT IS REQUIRED.
=======================================================
Fire and Explosion Hazard Information
=======================================================
Extinguishing Media: WATER, CO2, DRY CHEMICAL, FOAM/HALON.
=======================================================
Control Measures
=======================================================
Respiratory Protection: USE AN APPROVED RESPIRATOR
Ventilation: LABORATORY FUME HOOD/LOCAL EXHAUST VENTILATION.
Protective Gloves: CHEMICAL-RESISTANT
Eye Protection: SAFETY GLASSES
Other Protective Equipment: CHEMICAL-RESISTANT BODY COVERING. THE FOLLOWING
PROTECTION EQUIPMENT IS RECOMMENDED FOR A PRODUCTION SETTING.
Work Hygienic Practices: REMOVE/LAUNDER CONTAMINATED CLOTHING BEFORE REUSE.
Supplemental Safety and Health: APPROPRIATE SEIZURE PRECAUTIONS ARE ADVISED FOR
ANY PATIENT REGULARLY TAKING PROZAC WHO HAS BEEN EXPOSED TO AN ACUTE
OVERDOSE.
=======================================================
Physical/Chemical Properties
=======================================================
Spec Gravity: 1.2-1.3
PH: 2.5-5
Solubility in Water: COMPLETE
Appearance and Odor: CLEAR COLORLESS SOLUTION W/MINT-LIKE ODOR.
=======================================================
Reactivity Data
=======================================================
Stability Indicator: YES
Materials To Avoid: STRONG OXIDIZING AGENTS
Hazardous Decomposition Products: WHEN HEATED, MAY EMIT TOXIC FUMES.
Hazardous Polymerization Indicator: NO
=======================================================
Toxicological Information
=======================================================
=======================================================
Ecological Information
=======================================================
=======================================================
MSDS Transport Information
=======================================================
=======================================================
Regulatory Information
=======================================================
=======================================================
Other Information
=======================================================
=======================================================
HAZCOM Label
=======================================================
MSDS NAME: UC5017 FLUOXETINE HYDROCHLORIDE ORAL SOLUTION
Assigned IND: Y
Company: LILLY ELI & CO PHARMACEUTICAL DIV
Street: LILLY CORPORATE CENTER
City: INDIANAPOLIS IN
Zipcode: 46285
Health Emergency Phone: 317-276-2000/317-276-3494
Label Required IND: Y
Date Of Label Review: 12/16/1998
Status Code: C
Label Date: 12/16/1998
Origination Code: G
Hazard And Precautions: SKIN: CONTACT DERMATITIS HAS BEEN REPORTED
W/OCCUPATIONAL EXPOSURE TO FLUOXETINE HYDROCHLORIDE. OVERDOSE AFTER SUSTAINED
THERAPEUTIC EXPOSURE TO FLUOXETINE HYDROCHLORIDE HAS RESULTED IN SEIZURES.
CONTACT DERMATITIS HAS BEEN REPORTED W/OCCUPATIONAL EXPOSURE TO FLUOXETINE
HYDROCHLORIDE. OVERDOSE AFTER SUSTAINED THERAPEUTI C EXPOSURE TO FLUOXETINE
HYDROCHLORIDE HAS RESULTED IN SEIZURES.
=======================================================
Disclaimer (provided with this information by the compiling agencies): This
information is formulated for use by elements of the Department of Defense.
The United States of America in no manner whatsoever expressly or implied
warrants, states, or intends said information to have any application, use or
viability by or to any person or persons outside the Department of Defense
nor any person or persons contracting with any instrumentality of the United
States of America and disclaims all liability for such use. Any person
utilizing this instruction who is not a military or civilian employee of the
United States of America should seek competent professional advice to verify
and assume responsibility for the suitability of this information to their
particular situation regardless of similarity to a corresponding Department
of Defense or other government situation.